Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

mcgartland law Blog

Our Blog Explores Legal Options After A Dangerous Product Causes Injury

July 10, 2017
Distracted Pedestrian Deaths Are More Common

Distraction-Related Pedestrian Fatalities Are On The Rise Walking may seem like a safe, environmentally-friendly, and healthy way to get from one place to another. However, the Governors Highway Safety Association's (GHSA) recently released new statistics from its Spotlight on Pedestrian Traffic Fatalities report, which may cause some people to rethink their daily stroll.   More than 5,370 […]

Read More
May 17, 2017
Pradaxa May Be Safer Than Warfarin for Some AFib Patients

Pradaxa® Outperformed Warfarin In Study Of AFib Patients Undergoing Catheter Ablation In recent years, Pradaxa (dabigatran etexilate mesylate) has been linked to a number of uncontrollable and even deadly bleeding events. However, a March 2017 study comparing the safety and efficacy of Pradaxa and warfarin found that it may be a safer option for patients […]

Read More
May 11, 2017
PPI Related Kidney Decline Difficult to Detect

PPI Medications Linked To “Silent” Kidney Damage More than 20 million Americans fill prescriptions for proton pump inhibitor (PPI) medications each year in the United States, according to the U.S. Food and Drug Administration (FDA). Approved for the treatment of gastric-acid illnesses, such as chronic heartburn, peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), and […]

Read More
May 10, 2017
PPIs Linked to Increased Cardio Risks for CAD Patients

PPIs Linked To Increased Risk Of Heart Failure And Death In Patients With CAD Patients with coronary artery disease (CAD) rely on chronic antiplatelet therapy to mitigate the risks associated with their disease. These therapies often include aspirin and Plavix® (clopidogrel), both of which are notorious for causing gastrointestinal complications. Aspirin puts patients at risk for gastrointestinal ulcers and […]

Read More
May 9, 2017
How Proton Pump Inhibitors Damage Arteries

Study Offers Clues To How PPIs Damage Arteries Over Time Previous research into the efficacy and safety of acid-reducing proton pump inhibitors (PPIs) suggested a link between long-term use and a myriad of serious health problems, including artery damage and cardiovascular disease. However, until recently, researchers weren't able to explain how these drugs might inflict this damage. A 2016 […]

Read More
May 4, 2017
How Recalled Hip Implants Impact Stryker Bottom Line

Hip Implant Recalls Negatively Affect Stryker Q4 Earnings Stryker has come under fire in recent years for metal-on-metal hip replacement systems that fail prematurely, necessitating painful and invasive hip replacement or reconstructive surgeries. After voluntarily recalling two such components—the Rejuvenate and ABG II modular-neck hip stems—in 2012 over concerns of fretting and corrosion, the problematic devices are finally […]

Read More
May 3, 2017
Eliquis Outperformed Rivals in Recent Study

Bleeding-Related Costs Lower With Eliquis® Than Rivals Pradaxa® In a recent real-world study comparing the benefits of old-school warfarin and next-generation anticoagulants Eliquis (apixaban), and Pradaxa (dabigatran) for the treatment of non-valvular atrial fibrillation, Eliquis repeatedly came out on top in terms of efficacy, safety, and controlling bleeding-related costs. The study was presented at the American […]

Read More
April 14, 2017
Alternatives to Proton Pump Inhibitors

Alternatives To Proton Pump Inhibitors For Heartburn Relief Proton pump inhibitors (PPIs) such as Prilosec® (omeprazole), Prevacid® (lansoprazole), and Nexium® (esomeprazole) decrease stomach acid by inhibiting the enzyme responsible for its production, effectively treating a variety of peptic acid disorders, such as chronic heartburn and gastroesophageal reflux disease (GERD). Although quite adept at controlling stomach acid, PPIs have […]

Read More
April 13, 2017
Metal Hip Alternatives

Alternatives To Metal-On-Metal Hip Implants When natural hip joints fail due to overuse, arthritis, or injury, people often experience excruciating pain and severely limited mobility. For many, a total hip replacement surgery is the answer. In the past, this surgical procedure was reserved for elderly patients, but now patients are much younger, wanting to the […]

Read More
March 30, 2017
Childhood Asthma Linked to PPI Use During Pregnancy

Finnish Study Links Childhood Asthma Risk To PPI Use During Pregnancy Proton pump inhibitors, or PPIs, such as Prilosec® (omeprazole) and Nexium® (esomeprazole) are used to treat peptic-acid disorders, including gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), nonsteroidal anti-inflammatory drug-induced gastropathy and chronic heartburn. While PPIs are quite effective at banishing unwanted stomach acid, they've also been […]

Read More

call 1-866-832-9300 today for a free consultation

Our Blog Explores Legal Options After A Dangerous Product Causes Injury

July 10, 2017
Distracted Pedestrian Deaths Are More Common

Distraction-Related Pedestrian Fatalities Are On The Rise Walking may seem like a safe, environmentally-friendly, and healthy way to get from one place to another. However, the Governors Highway Safety Association's (GHSA) recently released new statistics from its Spotlight on Pedestrian Traffic Fatalities report, which may cause some people to rethink their daily stroll.   More than 5,370 […]

Read More
May 17, 2017
Pradaxa May Be Safer Than Warfarin for Some AFib Patients

Pradaxa® Outperformed Warfarin In Study Of AFib Patients Undergoing Catheter Ablation In recent years, Pradaxa (dabigatran etexilate mesylate) has been linked to a number of uncontrollable and even deadly bleeding events. However, a March 2017 study comparing the safety and efficacy of Pradaxa and warfarin found that it may be a safer option for patients […]

Read More
May 11, 2017
PPI Related Kidney Decline Difficult to Detect

PPI Medications Linked To “Silent” Kidney Damage More than 20 million Americans fill prescriptions for proton pump inhibitor (PPI) medications each year in the United States, according to the U.S. Food and Drug Administration (FDA). Approved for the treatment of gastric-acid illnesses, such as chronic heartburn, peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), and […]

Read More
May 10, 2017
PPIs Linked to Increased Cardio Risks for CAD Patients

PPIs Linked To Increased Risk Of Heart Failure And Death In Patients With CAD Patients with coronary artery disease (CAD) rely on chronic antiplatelet therapy to mitigate the risks associated with their disease. These therapies often include aspirin and Plavix® (clopidogrel), both of which are notorious for causing gastrointestinal complications. Aspirin puts patients at risk for gastrointestinal ulcers and […]

Read More
May 9, 2017
How Proton Pump Inhibitors Damage Arteries

Study Offers Clues To How PPIs Damage Arteries Over Time Previous research into the efficacy and safety of acid-reducing proton pump inhibitors (PPIs) suggested a link between long-term use and a myriad of serious health problems, including artery damage and cardiovascular disease. However, until recently, researchers weren't able to explain how these drugs might inflict this damage. A 2016 […]

Read More
May 4, 2017
How Recalled Hip Implants Impact Stryker Bottom Line

Hip Implant Recalls Negatively Affect Stryker Q4 Earnings Stryker has come under fire in recent years for metal-on-metal hip replacement systems that fail prematurely, necessitating painful and invasive hip replacement or reconstructive surgeries. After voluntarily recalling two such components—the Rejuvenate and ABG II modular-neck hip stems—in 2012 over concerns of fretting and corrosion, the problematic devices are finally […]

Read More
May 3, 2017
Eliquis Outperformed Rivals in Recent Study

Bleeding-Related Costs Lower With Eliquis® Than Rivals Pradaxa® In a recent real-world study comparing the benefits of old-school warfarin and next-generation anticoagulants Eliquis (apixaban), and Pradaxa (dabigatran) for the treatment of non-valvular atrial fibrillation, Eliquis repeatedly came out on top in terms of efficacy, safety, and controlling bleeding-related costs. The study was presented at the American […]

Read More
April 14, 2017
Alternatives to Proton Pump Inhibitors

Alternatives To Proton Pump Inhibitors For Heartburn Relief Proton pump inhibitors (PPIs) such as Prilosec® (omeprazole), Prevacid® (lansoprazole), and Nexium® (esomeprazole) decrease stomach acid by inhibiting the enzyme responsible for its production, effectively treating a variety of peptic acid disorders, such as chronic heartburn and gastroesophageal reflux disease (GERD). Although quite adept at controlling stomach acid, PPIs have […]

Read More
April 13, 2017
Metal Hip Alternatives

Alternatives To Metal-On-Metal Hip Implants When natural hip joints fail due to overuse, arthritis, or injury, people often experience excruciating pain and severely limited mobility. For many, a total hip replacement surgery is the answer. In the past, this surgical procedure was reserved for elderly patients, but now patients are much younger, wanting to the […]

Read More
March 30, 2017
Childhood Asthma Linked to PPI Use During Pregnancy

Finnish Study Links Childhood Asthma Risk To PPI Use During Pregnancy Proton pump inhibitors, or PPIs, such as Prilosec® (omeprazole) and Nexium® (esomeprazole) are used to treat peptic-acid disorders, including gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), nonsteroidal anti-inflammatory drug-induced gastropathy and chronic heartburn. While PPIs are quite effective at banishing unwanted stomach acid, they've also been […]

Read More

Contact our firm for a free consultation

Call us at 1-866-832-9300

McGartland Law Firm

Put A Top-Rated & Award-Winning Attorney To Work For You

30+ Years of Experience
Board Certified in Civil Trial Law
$1B In verdicts and settlements
experts in negligence related injuries
commentsphone-squarecaret-rightangle-downcrossmenucheckmark-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram